Home
Resources
Publications
Boron-containing Acids: Preliminary Evaluation of Acute Toxicity and Access to the Brain Determined by Raman Scattering Spectroscopy

Boron-containing Acids: Preliminary Evaluation of Acute Toxicity and Access to the Brain Determined by Raman Scattering Spectroscopy

Marvin A Soriano-Ursúa, Eunice D Farfán-García, Yessica López-Cabrera, Enrique Querejeta, José G Trujillo-Ferrara

Neurotoxicology. 2014 Jan;40:8-15.

PMID: 24189445

Abstract:

Boron-containing compounds (BCCs), particularly boron containing acids (BCAs), have become attractive moieties or molecules in drug development. It has been suggested that when functional groups with boron atoms are added to well-known drugs, the latter are conferred with greater potency and efficacy in relation to their target receptors. However, the use of BCAs in drug development is limited due to the lack of a toxicological profile. Consequently, the aim of the present study was to evaluate the acute toxicity of boric and boronic acids. Thus, a determination was made of the lethal dose (LD50) of test compounds in male CD1 mice, as well as the effective dose required to negatively affect spontaneous motor activity and to produce notable behavioral abnormalities. After treatment of animals at different doses, macroscopic observations were made from a necropsy, and Raman scattering spectroscopic studies were carried out on brain tissue samples. In general, the results show that most of the tested BCAs have very low toxicity, evidenced by the high doses required to induce notable toxic effects (greater than 100 mg/kg of body weight for all compounds, except for 3-thyenilboronic acid). Such toxic effects, presumably mediated by action on the CNS, include eye damage, gastrointestinal effects (e.g., gastric-gut dilatation and fecal retention), sedation, hypnosis and/or trembling. This preliminary toxicological profile suggests that BCAs can be considered potential therapeutic agents or moieties to be added to other compounds in the development of new drugs. Future studies are required to explore possible chronic toxicity of BCCs.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP247564712	2,3,6-Trifluorophenylboronic acid		247564-71-2	Price
AP871125701	3-Propoxy-2,4,6-trifluorophenylboronic acid		871125-70-1	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: